Vast global gap between funds needed to fight Covid-19, says WHO chief

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019

WHO
Dr Mike Ryan, head of WHO's emergencies programme, said the coronavirus was simple, brutal and cruel.
Reuters Geneva
3 min read Last Updated : Aug 11 2020 | 1:09 AM IST
There is a "vast global gap" between funds needed to fight the coronavirus pandemic and funds committed, World Health Organization chief Tedros Adhanom Ghebreyesus said on Monday, and the WHO was only "10% of the way" there.

More than 19.92 million people have been reported to be infected by the coronavirus globally and 729,883 have died, according to a Reuters tally.

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

"The coming three months present a crucial window of opportunity to scale-up the impact of the ACT Accelerator for global impact," Tedros told a briefing in Geneva, referring to the "Access to Covid-19 Tools" initiative.

"However to exploit this window, we have to fundamentally scale up the way we are funding the ACT Accelerator and prioritise the use of new tools. There is a vast global gap between our ambition for the ACT Accelerator, and the amount of funds that have been committed."

He said the WHO was only "10% of the way" to funding the billions of dollars required.


"For the vaccines alone, over $100 billion will be needed," Tedros said. This sounds like lot of money and it is.

"But it's small in comparison to the $10 trillion that have already been invested by G20 countries in fiscal stimulus to deal with the consequences of the pandemic so far." However, he said he saw "green shoots of hope".

"It is never too late to turn the pandemic around," Tedros said. The message is to "suppress, suppress, suppress".

Dr Mike Ryan, head of WHO's emergencies programme, said the coronavirus was simple, brutal and cruel.

"It's brutal in its simplicity, it is brutal in its cruelty, but it doesn't have a brain," he said. "We have the brains... we can outsmart something that doesn't have a brain but we are not doing such a great job right now." Ryan said that Brazil is registering 50,000-60,000 cases per day.

"Brazil is sustaining a very high level of epidemic, the curve is somewhat flattened, but it's not going down and the system is under great deal of pressure.

"In a situation like that, hydroxychloroquine is not a solution and not a silver bullet," he added, referring to the malaria drug which President Jair Bolsonaro has encouraged Brazilians to take against Covid-19.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusWorld Health OrganizationCOVID-19

Next Story